English 中文

Victor E. Tong, Jr.

Victor E. Tong, Jr.

Mr. Victor E. Tong, Jr. is a Partner at Decheng Capital and has been with the firm since its inception. At Decheng, Mr. Tong invests in diagnostics and life science tools, pharmaceutical and medical device companies in China and the US. Mr. Tong currently serves on the boards of Cirina, ReadCoor, SentreHeart and Shenzhen GeneMDx Biotech. Co. Ltd and is board observer of GenapSys and Accuragen. Other representative investments include 3SBio (1530.HK), GeneWeave Biosciences (acquired by Roche), Cellular Research (acquired by Becton Dickinson) and Invitae (NASDAQ:NVTA).

Prior to joining Decheng, Mr. Tong was a Principal at Bay City Capital and served as a board observer of Nevro (NYSE: NVRO). He played a key role in several transactions, including investments in Ion Torrent Systems (acquired by Life Technologies), NextWave Pharmaceuticals (acquired by Pfizer), Hyperion Therapeutics (acquired by Horizon Pharma), Cadence Pharmaceuticals (acquired by Mallinckrodt) and GenturaDx (acquired by Luminex). Prior to joining Bay City, Mr. Tong was an investment banker with Morgan Stanley, where he advised biotechnology, pharmaceutical, medical device and diagnostic companies on initial public offerings and specialized in strategic advisory work. Prior to joining Morgan Stanley, Mr. Tong was an entrepreneur at Hana Biosciences (acquired by Spectrum Pharmaceuticals), where he was responsible for pipeline development, licensing and product launch for cancer products. Mr. Tong began his career participating in The Human Genome Project and its race to sequence the human genome as a research assistant at Incyte in 1999. Mr. Tong is a graduate of the University of California, Berkeley, where he earned a BA degree in Molecular and Cell Biology and a BS degree in Business Administration from the Haas School of Business.



Min CuiMin Cui, Ph.D.
Managing Director
Dan ZabrowskiDan Zabrowski, Ph.D.
Venture Partner
Victor E. Tong, Jr.Victor E. Tong, Jr.
Ted DriscollTed Driscoll, Ph.D.
Qiang XuQiang Xu, Ph.D.
Nick PliamNick Pliam, M.D., Ph.D.

Tony TongTony Tong, Ph.D.
Vice President

Shasha DaiShasha Dai
Copyright © 2011 Decheng Capital LLC. All Rights Reserved.